PATENT CLAIM ANALYSIS

Application Number: 15922278
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-03
Patent Classification: ["424", "463000"]

Abstract:
Preparation and in vitro and in vivo characterization of novel forms of active pharmaceutical ingredients, suitable for pharmaceutical compositions in drug delivery systems for humans.

Claim (Index 13):
The enteric coated oral dosage form of  claim 11 , wherein the zoledronic acid molecular complex is a sodium salt of zoledronic acid.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.28571
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13567827', '15288139', '15819191', '15609641', '12847568']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8403134427972729
- 35 USC 102 Novelty (BERT): 0.6294422292278162
- Combined Prediction Score: 0.8192263214403273
- Mean Citation Score: 635.482208
- Max Citation Score: 689.8741
- Similarity Product: 507.98106296548247

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test